MedPath
HSA Approval

BEATROX FILM COATED TABLET 60MG

SIN16965P

BEATROX FILM COATED TABLET 60MG

BEATROX FILM COATED TABLET 60MG

February 27, 2024

BEACONS PHARMACEUTICALS PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBEACONS PHARMACEUTICALS PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

M01AH05

etoricoxib

Manufacturer Information

BEACONS PHARMACEUTICALS PTE. LTD.

Rontis Hellas Medical and Pharmaceutical Products S.A.

Active Ingredients

Etoricoxib

60 mg

Etoricoxib

Documents

Package Inserts

BEATROX FILM COATED TABLET PI.pdf

Approved: February 27, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

BEATROX FILM COATED TABLET 60MG - HSA Approval | MedPath